Binbin Liu
Zhejiang Chinese Medical University(CN)Tongji University(CN)Sun Yat-sen University(CN)China National Offshore Oil Corporation (China)(CN)Henan University of Science and Technology(CN)Chinese Academy of Sciences(CN)Fudan University(CN)Beijing Botanical Garden(CN)SAIC-GM (China)(CN)Sixth Affiliated Hospital of Sun Yat-sen University(CN)Zhongshan Hospital(CN)Shanghai Institute of Microsystem and Information Technology(CN)Ministry of Education(ET)Institute of Botany(CN)Tongji Hospital(CN)University of Chinese Academy of Sciences(CN)Huazhong University of Science and Technology(CN)
Publications by Year
Research Areas
Immunotherapy and Immune Responses, RNA modifications and cancer, Tuberculosis Research and Epidemiology, Cancer Immunotherapy and Biomarkers, Mycobacterium research and diagnosis
Most-Cited Works
- → Potent antimyeloma activity of the novel bromodomain inhibitors I-BET151 and I-BET762(2013)202 cited
- → Efficacy of Huoxiang Zhengqi dropping pills and Lianhua Qingwen granules in treatment of COVID-19: A randomized controlled trial(2020)188 cited
- → A comparison of the functional modules identified from time course and static PPI network data(2011)117 cited
- → SREBP1 promotes the invasion of colorectal cancer accompanied upregulation of MMP7 expression and NF-κB pathway activation(2019)108 cited
- → A novel long noncoding RNA AK001796 acts as an oncogene and is involved in cell growth inhibition by resveratrol in lung cancer(2015)105 cited
- → MicroRNA-622 functions as a tumor suppressor by targeting K-Ras and enhancing the anticarcinogenic effect of resveratrol(2011)101 cited